Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata Business Cycle Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Regular | Regular |
| Fund house | Tata | HDFC |
| NAV | ₹18.7331 | ₹22.8170 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 5.3 years | 3.1 years |
| Expense ratio | 2.2% | 2.1% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 38.00 | 93.90 |
Returns
| Tata Business Cycle Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 1 month | +6.60% | +12.87% |
| 3 months | −2.33% | +6.85% |
| 6 months | +1.38% | +17.20% |
| YTD | −1.34% | +32.43% |
| 1 year | −1.90% | +30.73% |
| 3 years (CAGR) | +8.94% | +29.16% |
| 5 years (CAGR) | +11.85% | — |
| 10 years (CAGR) | — | — |
| Since launch | +12.66% | +30.28% |
Risk
| Tata Business Cycle Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Volatility | 16.3% | 15.8% |
| Downside volatility | 11.3% | 8.6% |
| Sharpe | 0.15 | 1.44 |
| Sortino | 0.22 | 2.64 |
| Calmar | 0.44 | 1.94 |
| Return / risk | 0.55 | 1.85 |
| Deepest fall | −20.50% | −15.07% |
| Days to recover | — | 133 |
| Below its high | −9.41% | +0.00% |
Against benchmark
| Tata Business Cycle Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Alpha | −2.51% | +6.36% |
| Beta | 0.98 | 0.97 |
| R² | 93.8% | 85.0% |
| Up capture | 94.3% | 106.7% |
| Down capture | 107.3% | 74.4% |
| Tracking error | 4.1% | 6.1% |
| Information ratio | −0.64 | 0.97 |
| Treynor | 0.02 | 0.22 |
Consistency
| Tata Business Cycle Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Best 1-year | +55.11% | +64.96% |
| Middle 1-year | +8.65% | +21.84% |
| Worst 1-year | −11.49% | +0.52% |
| 1-year periods with a loss | 19.2% | 0.0% |
| Middle 3-year | +17.74% | +28.68% |
| Positive months | 63.9% | 69.4% |
| Best day | +4.03% | +3.19% |
| Worst day | −7.35% | −3.62% |
| Worst 5% day | −1.62% | −1.50% |
| Positive days | 56.1% | 58.1% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Tata Business Cycle Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 5-year XIRR | +9.77% | — |
| 5-year value | ₹7,71,179 | — |
| 3-year XIRR | +2.35% | +26.26% |
| 1-year XIRR | +1.67% | +39.84% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.